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 Abstract- Noninvasive Ventilation (NIV) is one 
of the best weapon at our disposal to treat respiratory 
failure. The early use of NIV out of the Intensive 
Care Unit can improve patients’ outcome.  
A 58-year-old man affected by severe bilateral 
pneumonia caused by Legionella Pneumophila was 
treated with Noninvasive Ventilation in extra 
Intensive Care Unit until the evidence of a marked 
improvement of clinical and radiological state. 




A 58-year-old Caucasian man came to our attention 
after a five days hospitalization due to fever, cough and 
progressive dyspnoea previously treated with amoxicillin 
without any results. In anamnesis, he was a bus driver,  no 
smoker, without relevant history of disease. At the 
admission at ER, he practiced routine laboratory tests, 
ECG and chest X-ray that showed the presence of bilateral 





Figure 1. Chest x-ray at the admission in ER. 
Evidence of large bilateral opacities.  
After the diagnosis of multifocal pneumonia, he was 
transferred to the Respiratory Medicine Division. At the 
clinical observation, the patient was significantly 
dyspnoeic at rest, presenting cyanosis, cough, profuse 
sweating in the absence of fever or thoracic pain, 
confusion, tachypnea but not bradycardia. At the 
auscultation, there was evidence of bilateral crepitation 
with major involvement of the medium left lung. Without 
oxygen support the patient showed a SatO2 of 62%, that 
increased to 74% under oxygen therapy (O2 4 lt/min). We 
performed sampling for Legionella Pneumophila’s urinary 
antigens and the patient underwent to an urgent chest x-
ray. The arterial blood gas analysis showed: pH 7.38, 
PaO2 33 mmHg, PaCO2 41 mmHg, HCO3 24.3, Sat O2 
62%. Blood tests reported: not elevated AST and ALT  
levels, a mild increased level of creatinine (1.5 mg/dl), a 
severe hyponatremia (125 mEq/lt), normal leukocytes 
with an increased level of neutrophils (7.700 /mm
3
; 95%). 
These results were accompanied by the increased amount 
of fibrinogen (980 mg/dl), D dimer (3.77 mg/lt), and pro-
calcitonin (8.48 mg/ml) [1]. 
Two scores were performed to evaluate the patient’s 
mortality rate: Fine’s score, 147 (V class, mortality rate 
about 27 %), and Curb-65 score, 3 (one-mount mortality 
rate 3%).  
A high resolution chest CT showed multiple bilateral 
parenchymal inflammatory foci extended to occupy 
almost the totality of the left lung and extensive areas of 
the contralateral lung (Figure 2A). 
A treatment was started based on the administration of 
ceftriaxone, methylprednisolone, clarithromycin, 
ranitidine, enoxaparin,  and mostly Noninvasive 
Ventilation (NIV).  
In Respiratory Medicine Division the diagnosis of 
Legionella pneumonia was confirmed by the detection of 
L. Pneumophila urinary 1 antigen serogroup and the 
treatment was confirmed. Since the beginning of this 
management protocol, the patient showed a gradual 
improvement, with a progressive reduction of FiO2 need. 
The Use of Noninvasive Ventilation Outside the Intensive Care Unit: 












Department of Respiratory Medicine, AOSG “San Giuseppe Moscati” Avellino 
2
Department of  Imaging, AOSG “San Giuseppe Moscati” Avellino 
3
Department of Medicine, University of Salerno 
 
Corresponding author: Annamaria Romano (annareromano@gmail.com) 
 
Translational Medicine @ UniSa, - ISSN 2239-9747 2013, 5(10): 34-36 
 
35 
Università degli Studi di Salerno 
 
Figure 2. Chest CT images. 
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A follow-up chest CT, performed after 7 days, 
demonstrated  the subtotal regression of the parenchymal 
foci previously reported, with a residual pleural effusion at 
the posterior basal left and right middle lobe and 
unventilated bands at the ventral segment of the upper 
lobe (Figure 2B).  
The Fine’s score decreased rapidly to 57 (II Class, 
mortality rate 0.9%), and the Curb score was 1 (one-
mount mortality about 17%). 
After 14 days since the hospitalization, the patient 
improved and was discharged.  
 
THE USE OF NIV OUTSIDE THE ICU 
 
Nowadays patients with respiratory failure are 
frequently ventilated using a noninvasive approach and in 
many conditions an early treatment with NIV is 
fundamental to improve the patient’s outcome.  The 
shortage and the high costs of an ICU bed require the use 
of NIV outside the ICU. The use of NIV should be 
recommended in ER and in Internal Medicine/ Respiratory 
Division. Although it is commonly accepted, few patients 
benefit of a NIV treatment outside the ICU [2,3]. Our aim 
is to prove the utility of NIV in respiratory failure and the 
possibility to apply NIV out of ICU without any 
difficulties even in a severe respiratory failure. 
The use of NIV in ordinary wards is necessary for the 
shortage of ICU beds, the new confidence in NIV 
management, and the possibility to use NIV in a early 
phase of the disease [4].  
Cabrini et al confirmed the efficacy of NIV outside 
the ICU, reporting a success rate about 77.5% for NIV 
outside the ICU in patients with Acute Respiratory Failure 
(ARF). They showed that the treatment failure was due to 
complications as nasal decubitus, malfunction of 
ventilator, incapacity to follow the NIV programme, air 
leaks from face mask. About 10,1 % of patients were 
intubated and 12.4 % were dead [5]. 
Despite these encouraging data, lately Cabrini et al 
reported that the  use of NIV in ordinary wards is reduced 
by the misperception of the efficacy of NIV among 
medical team in ordinary wards. Only the 28% of 
hospitals used NIV in all ordinary wards, even if about the 
70 % of them had a NIV programme [4]. Although NIV 
has been proved to optimize patients’ treatment in ARF, in 
pulmonary oedema or in post-operative respiratory failure, 
it is possible to obtain good outcomes where nurse and 
medical team is trained in NIV protocol [6,7]  
The best location for NIV treatment is where there is a 
staff with training and expertise in NIV, a staff available 
throughout 24h period, and with the opportunity of a rapid 
endotracheal intubation and an adequate monitoring. Basic 
monitoring during NIV requires the clinical observation, 
the continuous pulse oximetry, the periodical arterial 
blood gases, and the respiratory rate [6]. 
The early recognition of those patients that can be 
advantaged by the use of NIV, and the correct 
management of the ventilation programme are 
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